ロード中...
How we will treat chronic myeloid leukemia in 2016
Imatinib will become generic in 2016; assuming that its price will decrease precipitously, we expect that the economic forces will change our current practice habits. We reviewed the literature on the current recommendations to treat chronic myeloid leukemia and highlight how we plan to deal with th...
保存先:
| 出版年: | Blood Rev |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4385463/ https://ncbi.nlm.nih.gov/pubmed/25555325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2014.12.003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|